Ovarian cancer in female-to-male transsexuals: Report of two cases

Gynecologic Oncology

Volumn 76, Issue 3, 2000, Pages 413-415

  Hage, J J ^a   Dekker, J J M L ^a   Karim, R B ^a   Verheijen, R H M ^a   Bloemena, E ^a  

^a ACADEMIC MEDICAL CENTER   (Netherlands)

Author keywords

Androgens; Growth factors; Ovarian cancer; Polycystic ovaries; Transsexualism

Indexed keywords

TESTOSTERONE;

ADULT; ARTICLE; CANCER RISK; CASE REPORT; FEMALE; HISTOPATHOLOGY; HORMONE BLOOD LEVEL; HUMAN; HUMAN CELL; HUMAN TISSUE; LONG TERM EXPOSURE; MASTECTOMY; OVARY CANCER; PRIORITY JOURNAL; RISK FACTOR; SALPINGOOOPHORECTOMY; TRANSSEXUALISM;

EID: 0034056833     PISSN: 00908258     EISSN: None     Source Type: Journal    
DOI: 10.1006/gyno.1999.5720     Document Type: Article

References (12)

1. Repetto L, Granetto C, Aapro M, Pecorelli S. Gynaecologic cancers. Oncol Hematol. 27:1998;147-150.
2. Risch H A. Hormonal etiology of epithelial ovarian cancer, with a hypothesis concerning the role of androgens and progesterone. J Natl Cancer Inst. 23:1998;1774-1786.
3. van Kesteren P JM, Asscheman H, Megens J AJ, Gooren L JG. Mortality and morbidity in transsexual subjects treated with cross-sex hormones. Clin Endocrinol (Oxf). 47:1997;337-342.
4. Berns E MJJ, Klijn J GM, Henzen-Logmans S C, Rodenburg C J, van der Burg M EL, Foekens J A. Receptors for hormones and growth factors and (onco-)gene amplification in human ovarian cancer. Int J Cancer. 52:1992;218-224.
5. Balen A H, Schachter M E, Montgomery D, Reid R W, Jacobs H S. Polycystic ovaries are a common finding in untreated female to male transsexuals. Clin Endocrinol (Oxf). 38:1993;325-329.
6. Spinder T, Spijkstra J J, van den Tweel J G, Burger C W, van Kessel H, Hompes P GA, Gooren L JG. The effects of long term testosterone administration on pulsatile luteinizing hormone secretion and on ovarian histology in eugonadal female to male transsexual subjects. J Clin Endocrinol Metab. 69:1989;151-157.
7. Helzlsouer K J, Alberg A J, Gordon G B, Longcope C, Bush T L, Haoffman S C. Serum gonadotropins and steroid hormones and the development of ovarian cancer. J Am Med Assoc. 274:1995;1926-1930.
8. Elbers J MH, Asscheman H, Seidell J C, Megens J AJ, Gooren L JG. Long-term testosterone administration increases visceral fat in female-to-male transsexuals. J Clin Endocrinol Metab. 82:1997;2044.
9. Schildkraut J M, Schwingl P J, Bastos E, Evanoff A, Hughes C. Epithelial ovarium cancer risk among women with polycystic ovary syndrome. Obstet Gynecol. 88:1996;554-559.
10. Barlett M S, Langdon S P, Simpson B JB, Stewart M, Katsaros D, Sismondi P, Love S, Scott V N, Williams A RW, Lessells A M, Macleod K G, Smyth J F, Miller W R. The prognostic value of epidermal growth factor receptor mRNA expression in primary ovarian cancer. Br J Cancer. 73:1996;301-306.
11. Liu X-H, Wiley H S, Meikle A W. Androgens regulate proliferation of human prostate cancer cells in culture by increasing transforming growth factor-α (TGF-α) and epidermal growth factor (EGF)/TGA-α receptor. J Clin Endocrinol Metab. 77:1993;1472-1478.
12. Watson H, Franks S, Bonney R C. Regulation of epidermal growth factor receptor by androgens in human endometrial cells in culture. Hum Reprod. 13:1998;2585-2591.